Reassessing the Pediatric Dosing Recommendations for Unfractionated Heparin Using Real‐World Data: A Pharmacokinetic–Pharmacodynamic Modeling Approach-Reference-Cited by-同舟云学术

Reassessing the Pediatric Dosing Recommendations for Unfractionated Heparin Using Real‐World Data: A Pharmacokinetic–Pharmacodynamic Modeling Approach

Published:2022-01-12 Issue: Volume: Page:
ISSN:0091-2700
Container-title:The Journal of Clinical Pharmacology
language:en
Short-container-title:The Journal of Clinical Pharma

Author:

Salem Ahmed M.¹^ORCID,Niu Tao²,Li Chao³,Moffett Brady S.⁴⁵,Ivaturi Vijay¹^ORCID,Gopalakrishnan Mathangi¹^ORCID

Affiliation:

1. Center for Translational Medicine Department of Pharmacy Practice University of Maryland School of Pharmacy Baltimore Maryland USA

2. Modeling & Simulations Vertex Pharmaceuticals Boston Massachusetts USA

3. Fosun Pharma Princeton New Jersey USA

4. Department of Pharmacy Texas Children's Hospital Houston Texas USA

5. Department of Pediatrics Baylor College of Medicine Houston Texas USA

Publisher

Wiley

Subject

Pharmacology (medical),Pharmacology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/jcph.2007

Reference41 articles.

1. Antithrombotic therapy in neonates and children: antithrombotic therapy and prevention of thrombosis, 9th ed: American college of chest physicians evidence‐based clinical practice guidelines;Monagle P;Chest,2012

2. Systemic thromboembolism in children. Data from the 1‐800‐NO‐CLOTS consultation service;Kuhle S;Thromb Haemost,2004

3. Heparin and low‐molecular‐weight heparin: the Seventh ACCP conference on antithrombotic and thrombolytic therapy;Hirsh J;Chest,2004

4. Heparin clearance in the newborn;McDonald MM;Pediatr Res,1981

5. Age is a determinant factor for measures of concentration and effect in children requiring unfractionated heparin;Newall F;Thromb Haemost,2010

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Heparin Dosing Regimen Optimization in Veno-Arterial Extracorporeal Membrane Oxygenation: A Pharmacokinetic Analysis;Pharmaceutics;2024-06-06

2. Factors Influencing Unfractionated Heparin Pharmacokinetics and Pharmacodynamics During a Cardiopulmonary Bypass;Clinical Pharmacokinetics;2024-01-02

3. Pharmacokinetic Modeling Using Real‐World Data to Optimize Unfractionated Heparin Dosing in Pediatric Patients on Extracorporeal Membrane Oxygenation and Evaluate Target Achievement–Clinical Outcomes Relationship;The Journal of Clinical Pharmacology;2023-09

4. Model‐based approach to identify predictors of paclitaxel‐induced myelosuppression in “real‐world” administration;CPT: Pharmacometrics & Systems Pharmacology;2023-04-26